Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

No effect of a homoeopathic combination of Arnica montana and Bryonia alba on bleeding, inflammation, and ischaemia after aortic valve surgery.

  • 2010-01-21
  • British journal of clinical pharmacology 69(2)
    • Catherine Cornu
    • Pierre Joseph
    • Ségolène Gaillard
    • Christian Bauer
    • Catherine Vedrinne
    • Alvine Bissery
    • Ghislaine Melot
    • Nadine Bossard
    • Philippe Belon
    • Jean-Jacques Lehot

Study Design

Type
Randomized Controlled Trial (RCT)
Population
92 adult patients
Methods
randomly assigned to a double-blind parallel trial with either homoeopathic granules or a matching placebo until 4 days after surgery
Blinding
Double-blind
Duration
until 4 days after surgery

Aims

" Arnica montana is a popular homoeopathic treatment with potential haemostatic and anti-inflammatory properties. A homoeopathic combination of A. montana and Bryonia alba was used in aortic valve surgery to evaluate its effectiveness in reducing bleeding, inflammation, pain and myocardial ischaemia.

Methods

One day before surgery, 92 adult patients were randomly assigned to a double-blind parallel trial with either homoeopathic granules or a matching placebo until 4 days after surgery. The primary outcome was the volume of blood/liquid in the drains at their removal. The secondary outcomes included postoperative blood/liquid losses at 12 and 24 h as well as C-reactive protein (CRP), pain, temperature and plasma troponin Ic.

Results

At 12 h and 24 h after surgery, then at drain removal, blood losses in homoeopathy and placebo groups were not statistically significant (362 +/- 218, 520 +/- 269 and 640 +/- 297 ml vs. 456 +/- 440, 620 +/- 477 and 796 +/- 717 ml; P= 0.19, 0.23 and 0.35, respectively). The statistical modelling did not show significantly different patterns of CRP, troponin and body temperature changes or of pain perception. The number of transfused packed red cells was not significantly different either (P= 0.58). Two patients from each group died during the study period and the number of serious adverse events was not statistically different (six in homoeopathy vs. 10 in placebo groups; Fisher's exact test P= 0.41).

Conclusions

In the study setting, there was no evidence of effects of A. montana and B. alba combination on bleeding, inflammation, pain or myocardial ischaemia.

Research Insights

  • At 12 h and 24 h after surgery, then at drain removal, blood losses in homoeopathy and placebo groups were not statistically significant (362 +/- 218, 520 +/- 269 and 640 +/- 297 ml vs. 456 +/- 440, 620 +/- 477 and 796 +/- 717 ml; P= 0.19, 0.23 and 0.35, respectively).

    Effect
    Neutral
    Effect size
    Small
  • The statistical modelling did not show significantly different patterns of CRP, troponin and body temperature changes or of pain perception.

    Effect
    Neutral
    Effect size
    Small
  • The statistical modelling did not show significantly different patterns of CRP, troponin and body temperature changes or of pain perception.

    Effect
    Neutral
    Effect size
    Small
  • The statistical modelling did not show significantly different patterns of CRP, troponin and body temperature changes or of pain perception.

    Effect
    Neutral
    Effect size
    Small
  • The number of transfused packed red cells was not significantly different either (P= 0.58).

    Effect
    Neutral
    Effect size
    Small
  • The statistical modelling did not show significantly different patterns of CRP, troponin and body temperature changes or of pain perception.

    Effect
    Neutral
    Effect size
    Small

Adverse Events Reported

  • Bryoniadeath

    Two patients from each group died during the study period

    Finding
    No significant difference
    Severity
    Serious adverse event
    Significant
    No
  • Bryoniaserious adverse events

    the number of serious adverse events was not statistically different (six in homoeopathy vs. 10 in placebo groups; Fisher's exact test P= 0.41)

    Finding
    No significant difference
    Severity
    Serious adverse event
    Significant
    No
Back to top